Parliament adopts a proposal for the creation of a Special Committee on COVID-19

During the European Parliament’s Plenary session in Strasbourg, the Parliament adopted a proposal for the creation of a Special Committee on “COVID-19 pandemic: lessons learned and recommendations for the future”.

The Proposal for a decision states that the Committee aims to investigate how Europe responded to the pandemic and how the lessons learned may inform future action in the four areas listed below:

  • Health
    • This area mainly aims at analysing the European response to COVID-19, vaccine hesitancy, the effect of the pandemic on the healthcare sector such as medicines, healthcare workers, care services and the management of communicable and non-communicable diseases. It also covers the mandate of HERA, EMA and ECDC and the “One Health” Approach. It will additionally consider the role of the pharmaceutical industry in the pandemic response.
  • Coordinated approach with respect for democracy and fundamental rights
    • This area covers topics such as travelling restrictions, the use of technological tools, and inequality.
  • Societal and economic impact
    • This area aims to analyse the impact of the pandemic on poverty, inequalities, work organisation, domestic violence, education, hospitality sector, culture, and tourism.
  • EU and the World
    • This area focuses on international aspects of the pandemic and vaccine diplomacy, as well as the distribution of vaccines across the world.

The Committee will address topics for which in silico medicine could play an important role, including ensuring access to medicines and safe and effective vaccines. It would be crucial for our community to highlight the potential for (as well as successful use examples during COVID) of computer modelling and simulation for pandemic response and preparedness.

More information to come!

Date: 15/03/2022 | Tag: | News: 1297 of 1626
All news

News

  • 05/11/2024

    "In silico trials: an updated SWOT Analysis" released by In Silico World

    • The document comprehensively examines the strengths, weaknesses, opportunities, and threats for In Silico Trials in healthcare, providing a roadmap to help biomedical companies navigate and adopt these innovative methodologies. -Read more-
  • 31/10/2024

    In the literature: October 2024 highlights

    • Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter! -Read more-
  • 31/10/2024

    Joint motion for a resolution to revise the Medical Devices Regulation

    • The European Parliament has voted with a large majority to urge the European Commission to implement critical amendments to the EU Medical Device Regulation (MDR) by the first quarter of 2025. The drive for reform is intended to tackle pressing issues in the regulation, which has been criticised for its excessive bureaucracy and impact on patient care, jobs, and innovation in the medical device sector. -Read more-
  • 31/10/2024

    EU Budget for 2025 Prioritizes Research, Health, Education, and Climate Action

    • The European Parliament has presented their draft budget demanding an EU budget for 2025 that focuses on improving people's lives, boosting competitiveness, and addressing current challenges. MEPs are proposing a budget of nearly €201 billion, which exceeds the European Commission's initial proposal of around €199.76 billion. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO